|
US2003A
(en)
*
|
|
1841-03-12 |
|
Improvement in horizontal windivhlls |
|
US2002A
(en)
*
|
|
1841-03-12 |
|
Tor and planter for plowing |
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
DE3668186D1
(de)
|
1985-04-01 |
1990-02-15 |
Celltech Ltd |
Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert.
|
|
US5776093A
(en)
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US6225050B1
(en)
|
1986-04-18 |
2001-05-01 |
Carnegie Mellon University |
Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
|
|
DE3779221D1
(de)
|
1986-08-19 |
1992-06-25 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
|
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US5059680A
(en)
|
1986-11-24 |
1991-10-22 |
Centocor, Inc. |
Method of isolating ca 125 antigen
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US4921790A
(en)
|
1987-04-24 |
1990-05-01 |
Research Corporation |
Tumor specific assay for CA125 ovarian cancer antigen
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
WO1989001629A1
(en)
|
1987-08-19 |
1989-02-23 |
Centocor, Inc. |
Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3
|
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
|
US6013531A
(en)
|
1987-10-26 |
2000-01-11 |
Dade International Inc. |
Method to use fluorescent magnetic polymer particles as markers in an immunoassay
|
|
US5688657A
(en)
|
1988-03-31 |
1997-11-18 |
International Bio-Immune Systems, Inc. |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
|
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0394827A1
(en)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Chimaeric CD4-immunoglobulin polypeptides
|
|
US6156731A
(en)
|
1989-05-10 |
2000-12-05 |
G. D. Searle & Co. |
Polypeptide composition for oral administration
|
|
US5897861A
(en)
|
1989-06-29 |
1999-04-27 |
Medarex, Inc. |
Bispecific reagents for AIDS therapy
|
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
AU6031090A
(en)
|
1989-07-31 |
1991-03-11 |
University Of British Columbia, The |
Monoclonal antibodies against a tumor-associated antigen
|
|
WO1991006570A1
(en)
|
1989-10-25 |
1991-05-16 |
The University Of Melbourne |
HYBRID Fc RECEPTOR MOLECULES
|
|
CA2071867A1
(en)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
US5532135A
(en)
|
1990-02-02 |
1996-07-02 |
Cancer Research Fund Of Contra Costa |
Solid-phase competitive assay utilizing a fusion protein
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6197299B1
(en)
|
1990-07-20 |
2001-03-06 |
Pharmacia & Upjohn Ab |
Antibody conjugates
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
US6248332B1
(en)
|
1990-10-05 |
2001-06-19 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
GB9022543D0
(en)
|
1990-10-17 |
1990-11-28 |
Wellcome Found |
Antibody production
|
|
EP0557300B1
(en)
|
1990-10-29 |
1997-11-19 |
Chiron Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
US6099842A
(en)
|
1990-12-03 |
2000-08-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin
|
|
DE69123241T2
(de)
|
1990-12-14 |
1997-04-17 |
Cell Genesys Inc |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE69214709T2
(de)
|
1991-04-26 |
1997-02-20 |
Surface Active Ltd |
Neue Antikörper und Verfahren zu ihrer Verwendung
|
|
CA2109528A1
(en)
|
1991-05-01 |
1992-11-02 |
Gregory A. Prince |
A method for treating infectious respiratory diseases
|
|
USRE37525E1
(en)
|
1991-05-01 |
2002-01-22 |
Henry M. Jackson Foundation |
Method for treating infectious respiratory diseases
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
EP0940468A1
(en)
|
1991-06-14 |
1999-09-08 |
Genentech, Inc. |
Humanized antibody variable domain
|
|
JPH06508371A
(ja)
|
1991-06-21 |
1994-09-22 |
ユニバーシティー オブ シンシナティ |
経口投与できる治療用タンパク質及びその製法
|
|
US5844095A
(en)
|
1991-06-27 |
1998-12-01 |
Bristol-Myers Squibb Company |
CTLA4 Ig fusion proteins
|
|
US5366866A
(en)
|
1991-07-25 |
1994-11-22 |
Duke University |
Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
|
|
US6136310A
(en)
*
|
1991-07-25 |
2000-10-24 |
Idec Pharmaceuticals Corporation |
Recombinant anti-CD4 antibodies for human therapy
|
|
CA2115049C
(en)
|
1991-09-06 |
2003-10-21 |
Michael G. Rosenblum |
Dna sequences encoding gelonin polypeptide
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US5869619A
(en)
|
1991-12-13 |
1999-02-09 |
Xoma Corporation |
Modified antibody variable domains
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5976818A
(en)
|
1991-12-16 |
1999-11-02 |
The Board Of Trustees Of The University Of Arkansas |
Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
EP0627940B1
(en)
|
1992-03-05 |
2003-05-07 |
Board of Regents, The University of Texas System |
Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
|
WO1994004670A1
(en)
|
1992-08-26 |
1994-03-03 |
President And Fellows Of Harvard College |
Use of the cytokine ip-10 as an anti-tumor agent
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
JP3756512B2
(ja)
|
1992-09-21 |
2006-03-15 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
徐放性タンパク質製剤
|
|
US6277410B1
(en)
|
1992-10-08 |
2001-08-21 |
Supratek Pharma Inc. |
Copolymer compositions for oral delivery
|
|
US5441050A
(en)
|
1992-12-18 |
1995-08-15 |
Neoprobe Corporation |
Radiation responsive surgical instrument
|
|
US5863985A
(en)
|
1995-06-29 |
1999-01-26 |
Kinerton Limited |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
|
US6221958B1
(en)
|
1993-01-06 |
2001-04-24 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US5648218A
(en)
|
1993-02-12 |
1997-07-15 |
Sealite Sciences, Inc. |
Preparation of photoprotein conjugates and methods of use thereof
|
|
WO1994018955A1
(en)
|
1993-02-22 |
1994-09-01 |
Alza Corporation |
Compositions for oral delivery of active agents
|
|
JPH06247842A
(ja)
|
1993-02-23 |
1994-09-06 |
Green Cross Corp:The |
リポソーム組成物の製造方法
|
|
US5556623A
(en)
|
1993-03-30 |
1996-09-17 |
Eli Lilly And Company |
Antibody-drug conjugates
|
|
US5428156A
(en)
|
1993-04-02 |
1995-06-27 |
Associated Universities, Inc. |
Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
|
|
US5744119A
(en)
|
1993-05-11 |
1998-04-28 |
Sterling Winthrop |
Preparation of a radioconjugate formulation
|
|
EP0700305B1
(en)
|
1993-05-27 |
2000-01-26 |
Wagner, Uwe, Dr.med. |
Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
WO1995005864A1
(en)
|
1993-08-27 |
1995-03-02 |
Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Convection-enhanced drug delivery
|
|
SE9304060D0
(sv)
|
1993-12-06 |
1993-12-06 |
Bioinvent Int Ab |
Sätt att selektera specifika bakteriofager
|
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
DE69531148T2
(de)
|
1994-01-31 |
2004-04-29 |
Trustees Of Boston University, Boston |
Bibliotheken aus polyklonalen antikörpern
|
|
JPH09509054A
(ja)
|
1994-02-01 |
1997-09-16 |
アメリカ合衆国 |
抗体部分および非抗体部分を含む融合タンパク質
|
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US5596081A
(en)
|
1994-03-11 |
1997-01-21 |
University Of Kentucky Research Foundation |
Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
|
|
CN1150840A
(zh)
|
1994-04-14 |
1997-05-28 |
阿德科克因格拉姆有限公司 |
一种检测分枝杆菌属细菌存在的方法以及及其所用的试剂盒和抗体
|
|
AU2589095A
(en)
|
1994-05-16 |
1995-12-05 |
Washington University |
Cell membrane fusion composition and method
|
|
US6043099A
(en)
|
1994-05-17 |
2000-03-28 |
Spallholz; Julian E. |
Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6132764A
(en)
|
1994-08-05 |
2000-10-17 |
Targesome, Inc. |
Targeted polymerized liposome diagnostic and treatment agents
|
|
CA2195557C
(en)
|
1994-08-12 |
2006-10-17 |
Shui-On Leung |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
|
ATE208633T1
(de)
|
1994-09-16 |
2001-11-15 |
Merck Patent Gmbh |
Immunokonjugate
|
|
WO1996010585A1
(en)
|
1994-09-30 |
1996-04-11 |
Inex Pharmaceuticals Corp. |
Glycosylated protein-liposome conjugates and methods for their preparation
|
|
US6376170B1
(en)
|
1994-10-03 |
2002-04-23 |
The Scripps Research Institute |
Ligand capture-directed selection of antibody
|
|
DE69520044T2
(de)
|
1994-10-12 |
2001-06-13 |
Focal, Inc. |
Zielgerichte verabreichung mittels biologisch abbaubarer polymere
|
|
US5690935A
(en)
|
1995-01-13 |
1997-11-25 |
Regents Of The University Of Minnesota |
Biotherapy of cancer by targeting TP-3/P80
|
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US6086875A
(en)
|
1995-01-17 |
2000-07-11 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of immunogens
|
|
WO1996022111A1
(en)
|
1995-01-19 |
1996-07-25 |
Sound Science Limited Partnership |
Local delivery and monitoring of drugs
|
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
GB9506946D0
(en)
|
1995-04-04 |
1995-05-24 |
Univ Strathclyde |
Microgels
|
|
SE9501302D0
(sv)
|
1995-04-07 |
1995-04-07 |
Bioinvent Internatioal Ab |
Antibodies for use in cancertherapy and diagnosis
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
KR19980703876A
(ko)
|
1995-04-14 |
1998-12-05 |
스티븐 엘. 허스트 |
분산성이 개선된 분말화된 약학적 조성물
|
|
US5817624A
(en)
|
1995-06-05 |
1998-10-06 |
Alza Corporation |
Permeation enhancer compositions for increased absorption of therapeutic proteins through the colonic membrane
|
|
US5817789A
(en)
|
1995-06-06 |
1998-10-06 |
Transkaryotic Therapies, Inc. |
Chimeric proteins for use in transport of a selected substance into cells
|
|
US5879712A
(en)
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
|
US5759519A
(en)
|
1995-06-07 |
1998-06-02 |
Gen-Probe Incorporated |
Method for the intracellular delivery of biomolecules using thiocationic lipids
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
WO1997001331A2
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
|
WO1997002479A2
(en)
|
1995-06-30 |
1997-01-23 |
Yale University |
Human monoclonal anti-tumor antibodies
|
|
US5871941A
(en)
|
1995-07-28 |
1999-02-16 |
Univ British Columbia |
Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer
|
|
AU710347B2
(en)
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
JPH11513669A
(ja)
|
1995-10-13 |
1999-11-24 |
アメリカ合衆国 |
ジスルフィド安定化抗体フラグメントを含む免疫毒素
|
|
US5723125A
(en)
|
1995-12-28 |
1998-03-03 |
Tanox Biosystems, Inc. |
Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
|
|
US6194177B1
(en)
|
1996-02-20 |
2001-02-27 |
Applied Research Systems Ars Holding N.V. |
DNA encoding a hybrid heterodimeric protein
|
|
DK0885002T3
(da)
|
1996-03-04 |
2011-08-22 |
Penn State Res Found |
Materialer og fremgangsmåder til forøgelse af cellulær internalisering
|
|
AU5711196A
(en)
|
1996-03-14 |
1997-10-01 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
|
EP0904278A4
(en)
|
1996-03-22 |
1999-09-15 |
Human Genome Sciences Inc |
MOLECULE II INDUCER OF APOPTOSIS
|
|
DK0889722T3
(da)
|
1996-03-28 |
2003-02-10 |
Takeda Chemical Industries Ltd |
Præparat med forsinket frigivelse og fremstilling deraf
|
|
DE69730218D1
(de)
|
1996-04-11 |
2004-09-16 |
Univ British Columbia |
Fusogene liposomen
|
|
WO1997042973A1
(en)
|
1996-05-15 |
1997-11-20 |
Altarex, Corp. |
Method and composition for reconforming multi-epitopic antigens to initiate an immune response
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5800421A
(en)
|
1996-06-12 |
1998-09-01 |
Lemelson; Jerome H. |
Medical devices using electrosensitive gels
|
|
US6110750A
(en)
|
1996-06-28 |
2000-08-29 |
Sugden; Edward A. |
Rapid detection method of Mycobacterium bovis by fluorescence polarization
|
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US6420140B1
(en)
|
1996-10-11 |
2002-07-16 |
Abgenix, Inc. |
Production of multimeric protein by cell fusion method
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US6284375B1
(en)
|
1996-10-18 |
2001-09-04 |
Tuo Jin |
Lipid vesicle system
|
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
DE69719367T2
(de)
|
1996-12-20 |
2003-10-16 |
Takeda Chemical Industries, Ltd. |
Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
|
|
JPH10212246A
(ja)
|
1997-01-30 |
1998-08-11 |
Nippon Zoki Pharmaceut Co Ltd |
経口投与用製剤
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
SI0970126T1
(en)
|
1997-04-14 |
2001-08-31 |
Micromet Ag |
Novel method for the production of antihuman antigen receptors and uses thereof
|
|
US6020004A
(en)
|
1997-04-17 |
2000-02-01 |
Amgen Inc. |
Biodegradable microparticles for the sustained delivery of therapeutic drugs
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
JP2002510968A
(ja)
|
1997-05-07 |
2002-04-09 |
ブリストル−マイヤーズ スクイブ カンパニー |
組換え抗体−酵素融合タンパク質
|
|
JP3779798B2
(ja)
|
1997-06-26 |
2006-05-31 |
シスメックス株式会社 |
Ｃａ１２５の測定方法
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
US6238667B1
(en)
|
1997-09-19 |
2001-05-29 |
Heinz Kohler |
Method of affinity cross-linking biologically active immunogenic peptides to antibodies
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
US6008002A
(en)
|
1997-09-29 |
1999-12-28 |
Bodey; Bela |
Immunomagnetic detection and isolation of cancer cells
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
DE69839060T2
(de)
|
1997-11-03 |
2009-01-15 |
Human Genome Sciences, Inc. |
Vegi, ein inhibitor der angiogenese und des tumorwachstums
|
|
US6197523B1
(en)
|
1997-11-24 |
2001-03-06 |
Robert A. Levine |
Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
|
|
JP3786832B2
(ja)
|
1998-01-07 |
2006-06-14 |
デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム |
分解性のヘテロ二官能性ポリ（エチレングリコール）アクリレート及びそれから誘導されるゲル及び複合体
|
|
US6074689A
(en)
|
1998-03-10 |
2000-06-13 |
Immucell Corporation |
Colonic delivery of protein or peptide compositions
|
|
CA2336139C
(en)
|
1998-06-24 |
2008-10-14 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
|
US6245427B1
(en)
|
1998-07-06 |
2001-06-12 |
DüZGüNES NEJAT |
Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
|
|
US6670463B1
(en)
|
1998-12-17 |
2003-12-30 |
Corixa Corporation |
Compositions and methods for therapy of ovarian cancer
|
|
US6962980B2
(en)
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20030091580A1
(en)
|
2001-06-18 |
2003-05-15 |
Mitcham Jennifer L. |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6468546B1
(en)
*
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6528253B1
(en)
|
1998-12-17 |
2003-03-04 |
Corixa Corporation |
Compositions and methods for diagnosis of ovarian cancer
|
|
US6488931B1
(en)
|
1998-12-17 |
2002-12-03 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
|
US6858710B2
(en)
|
1998-12-17 |
2005-02-22 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US6699664B1
(en)
|
1998-12-17 |
2004-03-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
KR100288103B1
(ko)
|
1998-12-26 |
2001-05-02 |
윤덕용 |
폴리에테르가 그라프트된 생분해성 지방족 폴리에스테르 및 그의 제조방법
|
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
|
US6362317B1
(en)
|
1999-07-12 |
2002-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-γ-H2A antibody, fusion proteins thereof and method and kit for determining DNA double-stranded breaks
|
|
US6376654B1
(en)
|
1999-08-13 |
2002-04-23 |
Molecular Discoveries, Llc |
Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
|
|
US20020081609A1
(en)
|
1999-11-30 |
2002-06-27 |
Dillon Davin C. |
Compositions and methods for the therapy and diagnosis of breast cancer
|
|
AU1807401A
(en)
|
1999-11-30 |
2001-06-12 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of breast cancer
|
|
AU3483001A
(en)
|
2000-02-04 |
2001-08-14 |
Corixa Corp |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
US20030008299A1
(en)
|
2000-02-04 |
2003-01-09 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
|
WO2001060860A2
(en)
|
2000-02-17 |
2001-08-23 |
Millennium Predictive Medicine, Inc. |
Genes differentially expressed in human prostate cancer and their use
|
|
EP1268541A1
(en)
|
2000-03-17 |
2003-01-02 |
Human Genome Sciences, Inc. |
7 human ovarian and ovarian cancer associated proteins
|
|
AU4592601A
(en)
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
|
US7279294B2
(en)
|
2000-04-03 |
2007-10-09 |
The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih |
Tumor markers in ovarian cancer
|
|
CA2408547A1
(en)
|
2000-05-11 |
2001-11-15 |
Altarex Corp. |
Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
|
|
AU2001266787A1
(en)
|
2000-06-07 |
2002-01-08 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2002007783A2
(en)
|
2000-07-20 |
2002-01-31 |
Regents Of The University Of Minnesota |
Radiolabeled immunotoxins
|
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
EP1368475A4
(en)
|
2001-03-15 |
2004-10-20 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND NEW POLYPEPTIDES
|
|
AU2002335932B2
(en)
|
2001-03-21 |
2007-11-01 |
Altarex Medical Corp. |
Therapeutic compositions that alter the immune response
|
|
JP5232350B2
(ja)
*
|
2001-04-17 |
2013-07-10 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー |
Ｃａ１２５遺伝子のリピート配列並びに診断および治療的介入のためのその使用
|
|
US7309760B2
(en)
|
2001-04-17 |
2007-12-18 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
|
|
WO2002092836A2
(en)
|
2001-05-11 |
2002-11-21 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
|
|
EP1256354A1
(en)
|
2001-05-11 |
2002-11-13 |
Schering Corporation |
Methods for treating cancer
|
|
US7205142B2
(en)
|
2001-05-11 |
2007-04-17 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
DE10210239A1
(de)
|
2002-03-08 |
2003-09-25 |
Cellcontrol Biomedical Lab Ag |
Spezifische Ab1'-Antikörper gegen das Tumor-assoziierte Antigen CA125
|
|
CA2420494A1
(en)
|
2003-02-28 |
2004-08-28 |
Universite De Sherbrooke |
Ca 125 tumor antigen function and therapeutic uses thereof
|
|
EP1536814A4
(en)
|
2002-07-03 |
2006-02-15 |
Immunogen Inc |
ANTIQUE RPER AGAINST NON-SHED-MUC1 AND MUC16, AND ITS USES
|
|
MXPA05003884A
(es)
|
2002-10-16 |
2005-10-05 |
Euro Celtique Sa |
Anticuerpos que enlazan polipeptidos ca 125/0772p a celulas asociadas y metodos de uso de los mismos.
|
|
JP2006516189A
(ja)
|
2002-11-15 |
2006-06-29 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー |
Ｃａ１２５遺伝子、および診断および治療のためのその使用
|
|
WO2005039731A2
(en)
|
2003-10-24 |
2005-05-06 |
Cleveland Gas Systems Llc |
Spinning impingement multiphase contacting device
|